IL17A and myeloid sarcoma: The commonly implicated myelin-reactive CD4+ cells in the pathophysiology of MS are Th1 and Th17 lineage, defined on the basis of the production of interferon-γ (IFN-γ) and interleukin-17 (IL-17), respectively [16].